New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has established a blood-based test that could be used to predict the risk of Alzheimer’s disease up to 3.5 years before clinical diagnosis.
University of Missouri researchers made the discovery while using bioluminescent imaging technology to study how nicotinamide riboside supplements work inside the body.
Work in mice illuminates how pain neurons shield the gut from damage
It has been known for a long time that human brain disorders such as neurological or psychiatric diseases run in families, suggesting some heritability. In line with this hypothesis, genetic risk factors for developing these illnesses have been identified.